(Q54034077)

English

Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill.

scientific article published in September 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11025182

Activity of piperacillin/tazobactam in combination with amikacin, ciprofloxacin, and trovafloxacin against Pseudomonas aeruginosa by time-kill. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11025182

Pseudomonas aeruginosa

0 references

1 reference

based on heuristic

inferred from title

piperacillin/tazobactam

1 reference

based on heuristic

inferred from title

author name string

Burgess DS

1

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11025182

Hastings RW

2

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11025182

publication date

1 September 2000

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11025182

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11025182

38

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11025182

1

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11025182

37-41

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11025182

In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activities of combinations of aztreonam, ciprofloxacin, and ceftazidime against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of aztreonam combined with tobramycin and gentamicin against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of ciprofloxacin in combination with ceftazidime, aztreonam, and azlocillin against multiresistant isolates of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of methodologies for synergism testing of drug combinations against resistant strains of Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro activity of ciprofloxacin, levofloxacin, and trovafloxacin, alone and in combination with beta-lactams, against clinical isolates of Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Burkholderia cepacia

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial agent therapy for Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro synergy studies with ciprofloxacin and selected beta-lactam agents and aminoglycosides against multidrug-resistant Pseudomonas aeruginosa

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Timed killing kinetic studies of the interaction between ciprofloxacin and beta-lactams against gram-negative bacilli

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Pseudomonas aeruginosa revisited

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Determination of activities of levofloxacin, alone and combined with gentamicin, ceftazidime, cefpirome, and meropenem, against 124 strains of Pseudomonas aeruginosa by checkerboard and time-kill methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of antibiotic carry-over on bacterial counting by ‘spiral plating’

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2800%2900162-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(00)00162-0

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11025182

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 May 2018

http://europepmc.org/abstract/MED/11025182

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54034077&oldid=1562877668"